Insider Selling: Thomas Farrington Sells 1,741 Shares of Perrigo Company PLC Stock (PRGO)
Perrigo Company PLC (NASDAQ:PRGO) VP Thomas Farrington sold 1,741 shares of the company’s stock on the open market in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $150.36, for a total transaction of $261,776.76. Following the transaction, the vice president now directly owns 321 shares in the company, valued at approximately $48,266. The sale was disclosed in a filing with the SEC, which is available at this link.
Perrigo Company PLC (NASDAQ:PRGO) traded up 0.66% on Wednesday, hitting $149.94. The stock had a trading volume of 939,184 shares. Perrigo Company PLC has a 1-year low of $122.12 and a 1-year high of $168.39. The stock has a 50-day moving average of $149. and a 200-day moving average of $148.7. The company has a market cap of $20.065 billion and a P/E ratio of 84.15.
Perrigo Company PLC (NASDAQ:PRGO) last released its earnings data on Thursday, August 14th. The company reported $1.74 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.55 by $0.19. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. Analysts expect that Perrigo Company PLC will post $7.39 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 16th. Investors of record on Friday, August 29th will be given a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, August 27th.
A number of research firms have recently commented on PRGO. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo Company PLC in a research note on Monday, August 18th. They now have a $156.00 price target on the stock. Separately, analysts at B. Riley upgraded shares of Perrigo Company PLC from a “neutral” rating to a “buy” rating in a research note on Friday, August 15th. They now have a $180.00 price target on the stock, up previously from $157.00. Finally, analysts at Jefferies Group raised their price target on shares of Perrigo Company PLC from $160.00 to $176.00 in a research note on Friday, August 15th. They now have a “buy” rating on the stock. Three investment analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $166.92.
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Ratings for Perrigo Company PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.